KBL Merger Corp. IV (KBLM), filed a preliminary proxy this afternoon proposing to extend their current completion deadline of December 9, 2019 to April 9, 2020. KBLM announced they had signed a definitive agreement with CannBioRx, back on July 26, 2019, three months ago, but this new extension will give them an additional four months to close their combination.
As for the particulars, KBLM will be contributing $0.02 each month to the trust for shareholders that do not redeem at the extension vote, a slight reduction from the $0.0225 that KBLM previously offered to extend. Additionally, KBLM is requiring shareholders that wish to redeem MUST vote at this extension. That means any redeemers MUST be a shareholder of Record with the Record Date being November 8th.
So what does all this mean. For one, the fact that KBLM is requiring shareholders to vote typically indicates they are trying to reduce the amount of cash in trust. Meaning, they either have too much cash for the transaction to make sense or, they are trying to eliminate SPAC shareholders so they can replace them with an equity investor, a PIPE. However, whether that is done at a price substantially below trust value or at/near trust value remains to be seen. Either way, expect a significant number of redemptions at this vote due to the reduced contribution to trust and the required vote.


Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...
M3-Brigade V (NASDAQ:MBAV) has entered into a definitive agreement to combine with crypto treasury firm ReserveOne, assembling about $1 billion in equity funding. ReserveOne is setting up a diversified Bitcoin and digital asset treasury with a portion of its investments going towards blockchain infrastructure and venture raises. The combined company is expected to trade on...
At the SPAC of Dawn As the SPAC market has warmed in 2025, only 21 of the 70 SPACs (30%) that have IPO’d thus far have overfunded their trusts to draw in investors and none of these funded to more than 101%. By contrast, 87% of 2023 SPACs were overfunded – some to as high...
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...